Abstract:Background & Aims: Heterozygous inactivating mutations of Liver Kinase B1 (LKB1) are causative to the Peutz-Jeghers syndrome (PJS), a hereditary disease characterized by gastrointestinal polyposis and increased cancer susceptibility. While LKB1 loss-induced polyp formation has been ascribed to non-epithelial tissues, how LKB1 deficiency increases cancer risk of patients by altering the phenotypical landscape and hierarchical organization of epithelial tissues remains poorly understood. Methods: Using CRISPR/Cas9, we generated heterozygous and homozygous Lkb1-deficient mouse small intestinal organoids. These organoids were characterized by a combined approach that integrates imaging, bulk and single-cell RNA sequencing and growth assays. Our findings were validated in human PJS-derived tissues using immunohistochemistry and linked to colorectal cancer profiles using the TCGA cancer database. Results: Our results reveal that heterozygous Lkb1 loss is sufficient to push cells into a premalignant transcriptional program associated with serrated colorectal cancer, which is further amplified by loss-of-heterozygosity. This altered epithelial growth state associates with persistent features of regeneration and enhanced EGFR ligand and receptor expression, conferring niche-independent growth properties to Lkb1-deficient organoids. Moreover, LKB1 loss-of-function mutations co-occur with serrated colorectal cancer driver mutations for which synergistic cooperation was experimentally confirmed for Kras mutation and Lkb1-deficiency by assessing growth properties and transcriptomes. Conclusions: Heterozygous loss of LKB1 pushes intestinal cells into a chronic regenerative state which is amplified upon loss-of-heterozygosity. Lkb1-deficiency thereby establishes fertile ground for serrated colorectal cancer formation in the intestine, explaining the increased cancer risk observed in PJS.

LKB 1 Gene Mutation and Cancer Incidence in Peutz-Jeghers Patients

Germline Mutations of the Lkb1 (stk11) Gene in Peutz-Jeghers Patients

Clinical characteristics and mutation analysis of the LKB1 gene in a Peutz-Jeghers syndrome pedigree

Loss of Heterozygosity of LKB1 in Tumors from Peutz-Jeghers Syndrome Patients and Its Cancer Predisposing Mechanism

Must Peutz-Jeghers syndrome patients have the LKB1/STK11 gene mutation? A case report and review of the literature

Analysis on 36 Cases of Peutz-Jeghers Syndrome

The Peutz-Jegher Gene Product LKB1 is a Mediator of P53-Dependent Cell Death.

Analysis of STK11 gene variant in five Chinese patients with Peutz-Jeghers syndrome

Mutations Analysis Ofstk 11 Gene in Chinese Families with Peutz-Jeghers Syndrome

Advance of Molecular Genetic Researches of Peutz-Jeghers Syndrome

[Current research status of Peutz-Jeghers syndrome in children]

Very high risk of cancer in familial Peutz-Jeghers syndrome.

Clinical Characteristics and Stk11 Gene Mutations in Chinese Children with Peutz-Jeghers Syndrome

Clinical and Molecular Analysis in Patients with Peutz-Jeghers Syndrome

A Clinical and Molecular Genetic Study in 11 Chinese Children With Peutz-Jeghers Syndrome.

Intestinal LKB1 loss drives a pre-malignant program along the serrated cancer pathway

Detection and analysis of common pathogenic germline mutations in Peutz-Jeghers syndrome

Clinical Characteristics And Genetic Analysis Of Gene Mutations In A Chinese Pedigree With Peutz-Jeghers Syndrome

Advance of the research in the tumor suppressor gene LKB1

Immune profiling of premalignant lesions in patients with Peutz-Jeghers syndrome

[Clinical Analysis of Peutz-Jeghers Syndrome:A Report of 6 Cases].